Related Experiment Video
Updated: Jun 9, 2026

Simultaneous Visualization of the Dynamics of Crosslinked and Single Microtubules In Vitro by TIRF Microscopy
Published on: February 18, 2022
Symplekin specifies mitotic fidelity by supporting microtubule dynamics
Kathryn M Cappell1, Brittany Larson, Noah Sciaky
1Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.
Abstract:
Using a pangenomic loss-of-function screening strategy, we have previously identified 76 potent modulators of paclitaxel responsiveness in non-small-cell lung cancer. The top hit isolated from this screen, symplekin, is a well-established component of the mRNA polyadenylation machinery. Here, we performed a high-resolution phenotypic analysis to reveal the mechanistic underpinnings by which symplekin depletion collaborates with paclitaxel. We find that symplekin supports faithful mitosis by contributing to the formation of a bipolar spindle apparatus. Depletion of symplekin attenuates microtubule polymerization activity as well as expression of the critical microtubule polymerization protein CKAP5 (TOGp). Depletion of additional members of the polyadenylation complex induces similar phenotypes, suggesting that polyadenylation machinery is intimately coupled to microtubule function and thus mitotic spindle formation. Importantly, tumor cells depleted of symplekin display reduced fecundity, but the mitotic defects that we observe are not evident in immortalized cells. These results demonstrate a critical connection between the polyadenylation machinery and mitosis and suggest that tumor cells have an enhanced dependency on these components for spindle assembly.
Insights
Symplekin, a key part of mRNA processing, is crucial for cell division in non-small cell lung cancer. Its depletion impairs mitosis, offering new targets for paclitaxel cancer therapy.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Paclitaxel is a chemotherapy agent used for non-small cell lung cancer (NSCLC).
- Identifying novel drug targets is crucial for improving NSCLC treatment efficacy.
- Symplekin is known to be involved in mRNA processing.
Purpose of the Study:
- To elucidate the mechanism by which symplekin depletion affects paclitaxel responsiveness in NSCLC.
- To investigate the role of symplekin in mitotic processes and its interaction with paclitaxel.
Main Methods:
- Pangenomic loss-of-function screening to identify modulators of paclitaxel responsiveness.
- High-resolution phenotypic analysis to study symplekin's function.
- Assessment of microtubule polymerization and spindle apparatus formation.
- Analysis of CKAP5 (TOGp) expression levels.
Main Results:
- Symplekin is essential for the formation of a bipolar spindle apparatus, ensuring faithful mitosis.
- Symplekin depletion reduces microtubule polymerization and the expression of CKAP5 (TOGp).
- Depletion of other mRNA polyadenylation complex members phenocopies symplekin depletion, linking polyadenylation to microtubule function.
- Tumor cells with symplekin depletion show reduced proliferation and enhanced dependency on symplekin for spindle assembly.
Conclusions:
- The mRNA polyadenylation machinery, including symplekin, is intimately coupled to microtubule function and mitotic spindle formation.
- Symplekin plays a critical role in mitosis, and its depletion sensitizes cancer cells to paclitaxel.
- Targeting symplekin or related polyadenylation factors may represent a novel therapeutic strategy for NSCLC.
Related Concept Videos
Microtubule Instability
Microtubule Instability
Destabilization of Microtubules
The Mitotic Spindle
The bipolar configuration of the mitotic spindle facilitates chromosomal segregation, preparing the cell for division. One mechanism that ensures bipolar mitotic...
Microtubule Associated Proteins (MAPs)
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...

